Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vapor Ablation for Localized Cancer Lesions of the Lung - A Clinical Feasibility Treat-and Resect Study (VAPORIZE)

NCT03198468 is registered in ClinicalTrials.gov with Uptake Medical Technology, Inc. as lead sponsor.

NCT NCT03198468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03198468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vapor Ablation for Localized Cancer Lesions of the Lung - A Clinical Feasibility Treat-and Resect Study (VAPORIZE)
Lead sponsor
Uptake Medical Technology, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 21, 2018
Completion date
August 20, 2019
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, metastatic lung cancer, non small cell lung cancer